Neeraj Agarwal, MD

Cancer.Net Specialty Editor: Genitourinary Cancer
Huntsman Cancer Institute, Salt Lake City, UT

Dr. Neeraj Agarwal is a Professor of Medicine, physician, and an investigator at the Huntsman Cancer Institute (HCI), University of Utah. At the HCI, he directs the Genitourinary Oncology Program, the Center of Investigational Therapeutics, co-leads the Experimental Therapeutic Program, and serves on the cabinet of the Director of the HCI.

After receiving his medical degree from All India Institute of Medical Sciences in New Delhi, India, Dr. Agarwal completed a residency in internal medicine, and a fellowship in geriatric medicine at the University of Iowa. He then completed a hematology-oncology fellowship at the HCI at the University of Utah.

Dr. Agarwal has authored more than 250 peer-reviewed articles and book chapters. He has been invited to give talks at several national and international forums, including the National Institute of Health, and the annual meetings of ASCO, Society of Urology Oncology, and Kidney Cancer Association, Brazilian Society of Urology, Spanish Genitourinary Oncology Group, and various National Cancer Institute (NCI) designated comprehensive cancer centers across the country. He serves as a panel member for the National Comprehensive Cancer Network guideline committees for bladder and kidney cancer, and as a consultant to the Oncologic Drug Advisory Committee to the U.S. Food and Drug Administration.

Dr. Agarwal is the overall study chair of multiple clinical trials and is leading several other clinical trials as one of the steering committee members. Dr. Agarwal is a member of several professional societies, including ASCO, the American Association of Cancer Research, and SWOG Cancer Research Network.

Dr. Agarwal has the prestigious honor of being chosen as one of the five SWOG young investigators in 2009, as the leader of early therapeutics of the SWOG Genitourinary Cancer Scientific Leadership Committee in 2010, receiving the 2009-2010 William D. Odell Young Investigator award, and the 2014 Cancer Clinical Investigator Team Leadership Award from the NCI. In 2018, he was appointed as Huntsman Cancer Institute Presidential Endowed Chair of Cancer Research.

View current ASCO disclosure here.

Last updated: January 2020